The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

HealthDay News — Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes, according to a study published online Jan.

Some people who use semaglutide (Ozempic ... (Wegovy is approved to help manage weight in people with overweight or obesity.) However, no known studies show this potential effect with Ozempic ...

particularly in people with obesity. It’s totally valid to wonder what happens next if you have significant side effects while taking semaglutide for weight loss. There are several possibilities ...